-
2
-
-
0024424270
-
Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
-
Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073 (Pubitemid 19231814)
-
(1989)
Science
, vol.245
, Issue.4922
, pp. 1066-1073
-
-
Riordan, J.R.1
Rommens, J.M.2
Kerem, B.-S.3
Alon, N.4
Rozmahel, R.5
Grzelczak, Z.6
Zielinski, J.7
Lok, S.8
Plavsic, N.9
Chou, J.-L.10
Drumm, M.L.11
Iannuzzi, M.C.12
Collins, F.S.13
Tsui, L.-C.14
-
3
-
-
33644833532
-
Risk factors for death of patients with cystic fibrosis awaiting lung transplantation
-
DOI 10.1164/rccm.200410-1369OC
-
Belkin RA, Henig NR, Singer LG, et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006; 173:659-666 (Pubitemid 43363808)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.173
, Issue.6
, pp. 659-666
-
-
Belkin, R.A.1
Henig, N.R.2
Singer, L.G.3
Chaparro, C.4
Rubenstein, R.C.5
Xie, S.X.6
Yee, J.Y.7
Kotloff, R.M.8
Lipson, D.A.9
Bunin, G.R.10
-
4
-
-
0034810513
-
Wasting as an independent predictor of mortality in patients with cystic fibrosis
-
DOI 10.1136/thorax.56.10.746
-
Sharma R, Florea VG, Bolger AP, et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001; 56: 746-750 (Pubitemid 32917542)
-
(2001)
Thorax
, vol.56
, Issue.10
, pp. 746-750
-
-
Sharma, R.1
Florea, V.G.2
Bolger, A.P.3
Doehner, W.4
Florea, N.D.5
Coats, A.J.S.6
Hodson, M.E.7
Anker, S.D.8
Henein, M.Y.9
-
5
-
-
0035814353
-
Survival effect of lung transplantation among patients with cystic fibrosis
-
Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. Jama 2001; 286: 2683-2689 (Pubitemid 33135074)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.21
, pp. 2683-2689
-
-
Liou, T.G.1
Adler, F.R.2
Cahill, B.C.3
Fitzsimmons, S.C.4
Huang, D.5
Hibbs, J.R.6
Marshall, B.C.7
-
6
-
-
0034480351
-
A model for predicting life expectancy of children with cystic fibrosis
-
DOI 10.1034/j.1399-3003.2000.16f06.x
-
Aurora P, Wade A, Whitmore P, Whitehead B. A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 2000; 16: 1056-1060 (Pubitemid 32148117)
-
(2000)
European Respiratory Journal
, vol.16
, Issue.6
, pp. 1056-1060
-
-
Aurora, P.1
Wade, A.2
Whitmore, P.3
Whitehead, B.4
-
7
-
-
0026520359
-
Prediction of mortality in patients with cystic fibrosis
-
Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1187-1191
-
(1992)
N Engl J Med
, vol.326
, pp. 1187-1191
-
-
Kerem, E.1
Reisman, J.2
Corey, M.3
Canny, G.J.4
Levison, H.5
-
8
-
-
33947733672
-
Third International Workshop on Lung Tumor and differentiation antigens: Overview of the results of the central data analysis
-
DOI 10.1002/ijc.2910570704
-
Stahel RA, Gilks WR, Lehmann HP, Schenker T. Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis. Int J Cancer Suppl 1994; 8: 6-26. (Pubitemid 24188951)
-
(1994)
International Journal of Cancer
, vol.57
, Issue.SUPPL. 8
, pp. 6-26
-
-
Stahel, R.A.1
Gilks, W.R.2
Lehmann, H.-P.3
Schenker, T.4
-
9
-
-
0024332651
-
New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6
-
Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989; 96: 68-73.
-
(1989)
Chest
, vol.96
, pp. 68-73
-
-
Kohno, N.1
Kyoizumi, S.2
Awaya, Y.3
Fukuhara, H.4
Yamakido, M.5
Akiyama, M.6
-
10
-
-
0141887266
-
Circulating KL-6 levels in patients with drug induced pneumonitis
-
DOI 10.1136/thorax.58.10.872
-
Ohnishi H, Yokoyama A, Yasuhara Y, et al . Circulating KL-6 levels in patients with drug induced pneumonitis. Thorax 2003; 58: 872-875 (Pubitemid 37239235)
-
(2003)
Thorax
, vol.58
, Issue.10
, pp. 872-875
-
-
Ohnishi, H.1
Yokoyama, A.2
Yasuhara, Y.3
Watanabe, A.4
Naka, T.5
Hamada, H.6
Abe, M.7
Nishimura, K.8
Higaki, J.9
Ikezoe, J.10
Kohno, N.11
-
11
-
-
0029919580
-
Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis
-
Kobayashi J, Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 1996; 109: 1276-1282 (Pubitemid 26145667)
-
(1996)
Chest
, vol.109
, Issue.5
, pp. 1276-1282
-
-
Kobayashi, J.1
Kitamura, S.2
-
12
-
-
0031739485
-
Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis
-
Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998; 158: 1294-1298 (Pubitemid 28489035)
-
(1998)
American Journal of Respiratory and Critical Care Medicine
, vol.158
, Issue.4
, pp. 1294-1298
-
-
Takahashi, T.1
Munakata, M.2
Suzuki, I.3
Kawakami, Y.4
-
13
-
-
33644828168
-
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
-
DOI 10.1111/j.1440-1843.2006.00834.x
-
Yokoyama A, Kondo K, Nakajima M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164-168 (Pubitemid 43356896)
-
(2006)
Respirology
, vol.11
, Issue.2
, pp. 164-168
-
-
Yokoyama, A.1
Kondo, K.2
Nakajima, M.3
Matsushima, T.4
Takahashi, T.5
Nishimura, M.6
Bando, M.7
Sugiyama, Y.8
Totani, Y.9
Ishizaki, T.10
Ichiyasu, H.11
Suga, M.12
Hamada, H.13
Kohno, N.14
-
14
-
-
0037260159
-
High serum concentrations of surfactant protein a in usual interstitial pneumonia compared with non-specific interstitial pneumonia
-
DOI 10.1136/thorax.58.1.52
-
Ishii H, Mukae H, Kadota J, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with nonspecific interstitial pneumonia. Thorax 2003; 58: 52-57 (Pubitemid 36135359)
-
(2003)
Thorax
, vol.58
, Issue.1
, pp. 52-57
-
-
Ishii, H.1
Mukae, H.2
Kadota, J.3
Kaida, H.4
Nagata, T.5
Abe, K.6
Matsukura, S.7
Kohno, S.8
-
15
-
-
0036159142
-
Serum KL-6 levels in pediatric patients: Reference values for children and levels in pneumonia, asthma, and measles patients
-
DOI 10.1002/ppul.10044
-
Imai T, Takase M, Takeda S, Kougo T. Serum KL-6 levels in pediatric patients: reference values for children and levels in pneumonia, asthma, and measles patients. Pediatr Pulmonol 2002; 33: 135-141 (Pubitemid 34123690)
-
(2002)
Pediatric Pulmonology
, vol.33
, Issue.2
, pp. 135-141
-
-
Imai, T.1
Takase, M.2
Takeda, S.3
Kougo, T.4
-
16
-
-
0030936491
-
Exercise testing and prognosis in adult cystic fibrosis
-
Moorcroft AJ, Dodd ME, Webb AK. Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997; 52: 291-293 (Pubitemid 27128185)
-
(1997)
Thorax
, vol.52
, Issue.3
, pp. 291-293
-
-
Moorcroft, A.J.1
Dodd, M.E.2
Webb, A.K.3
-
17
-
-
0031950258
-
Risk of death in cystic fibrosis patients with severely compromised lung function
-
Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998; 113: 1230-1234
-
(1998)
Chest
, vol.113
, pp. 1230-1234
-
-
Milla, C.E.1
Warwick, W.J.2
-
18
-
-
33751208316
-
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria
-
DOI 10.1136/thx.2006.061366
-
Block JK, Vandemheen KL, Tullis E, et al. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax 2006; 61: 969-974 (Pubitemid 44787167)
-
(2006)
Thorax
, vol.61
, Issue.11
, pp. 969-974
-
-
Block, J.K.1
Vandemheen, K.L.2
Tullis, E.3
Fergusson, D.4
Doucette, S.5
Haase, D.6
Berthiaume, Y.7
Brown, N.8
Wilcox, P.9
Bye, P.10
Bell, S.11
Noseworthy, M.12
Pedder, L.13
Freitag, A.14
Paterson, N.15
Aaron, S.D.16
-
19
-
-
0034047708
-
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation
-
McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000; 161: 1877-1880 (Pubitemid 30418123)
-
(2000)
American Journal of Respiratory and Critical Care Medicine
, vol.161
, Issue.6
, pp. 1877-1880
-
-
McColley, S.A.1
Stellmach, V.2
Boas, S.R.3
Jain, M.4
Crawford, S.E.5
-
20
-
-
34147150127
-
Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis
-
DOI 10.1016/j.jcf.2006.10.005, PII S1569199306001305
-
Carlsson M, Eriksson L, Pressler T, et al. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. J Cyst Fibros 2007; 6: 228-233 (Pubitemid 46567795)
-
(2007)
Journal of Cystic Fibrosis
, vol.6
, Issue.3
, pp. 228-233
-
-
Carlsson, M.1
Eriksson, L.2
Pressler, T.3
Kornfalt, R.4
Mared, L.5
Meyer, P.6
Wiik, A.7
Wieslander, J.8
Segelmark, M.9
-
21
-
-
0027174515
-
Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis
-
Meyer K C, Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993; 121: 654-661 (Pubitemid 23148691)
-
(1993)
Journal of Laboratory and Clinical Medicine
, vol.121
, Issue.5
, pp. 654-661
-
-
Meyer, K.C.1
Zimmerman, J.2
-
22
-
-
0027131471
-
Alpha1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis
-
O'Connor CM, Gaffney K, Keane J, et al. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993; 148: 1665-1670 (Pubitemid 2024138)
-
(1993)
AM.REV.RESPIR.DIS.
, vol.148
, Issue.6 PART 1
, pp. 1665-1670
-
-
O'Connor, C.M.1
Gaffney, K.2
Keane, J.3
Southey, A.4
Byrne, N.5
O'Mahoney, S.6
Fitzgerald, M.X.7
-
24
-
-
0033962098
-
Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8
-
Taggart C, Coakley RJ, Greally P, Canny G, O'Neill SJ, McElvaney NG. Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol 2000; 278: L33-41.
-
(2000)
Am J Physiol Lung Cell Mol Physiol
, vol.278
-
-
Taggart, C.1
Coakley, R.J.2
Greally, P.3
Canny, G.4
O'Neill, S.J.5
McElvaney, N.G.6
-
25
-
-
0032864036
-
Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease
-
Osika E, Cavaillon JM, Chadelat K, et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 1999; 14: 339-346 (Pubitemid 29461299)
-
(1999)
European Respiratory Journal
, vol.14
, Issue.2
, pp. 339-346
-
-
Osika, E.1
Cavaillon, J.-M.2
Chadelat, K.3
Boule, M.4
Fitting, C.5
Tournier, G.6
Clement, A.7
-
27
-
-
0027319929
-
KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease
-
Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993; 148: 637-642 (Pubitemid 23263772)
-
(1993)
American Review of Respiratory Disease
, vol.148
, Issue.3
, pp. 637-642
-
-
Kohno, N.1
Awaya, Y.2
Oyama, T.3
Yamakido, M.4
Akiyama, M.5
Inoue, Y.6
Yokoyama, A.7
Hamada, H.8
Fujioka, S.9
Hiwada, K.10
-
28
-
-
0030871286
-
Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis
-
Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 1997; 156: 109-115 (Pubitemid 27293174)
-
(1997)
American Journal of Respiratory and Critical Care Medicine
, vol.156
, Issue.1
, pp. 109-115
-
-
Inoue, Y.1
Barker, E.2
Daniloff, E.3
Kohno, N.4
Hiwada, K.5
Newman, L.S.6
-
29
-
-
27844571322
-
KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts
-
DOI 10.1016/j.bbrc.2005.10.144, PII S0006291X05024150
-
Ohshimo S, Yokoyama A, Hattori N, Ishikawa N, Hirasawa Y, Kohno N. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts. Biochem Biophys Res Commun 2005; 338: 1845-1852 (Pubitemid 41643100)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.338
, Issue.4
, pp. 1845-1852
-
-
Ohshimo, S.1
Yokoyama, A.2
Hattori, N.3
Ishikawa, N.4
Hirasawa, Y.5
Kohno, N.6
-
30
-
-
0031253164
-
KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts
-
Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997; 17: 501-507 (Pubitemid 127500983)
-
(1997)
American Journal of Respiratory Cell and Molecular Biology
, vol.17
, Issue.4
, pp. 501-507
-
-
Hirasawa, Y.1
Kohno, N.2
Yokoyama, A.3
Inoue, Y.4
Abe, M.5
Hiwada, K.6
-
31
-
-
0033058576
-
Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy
-
DOI 10.1007/s005950050372
-
Sakuma T, Takahashi K, Ohya N, Usuda K, Handa M. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy. Surg Today 1999; 29: 121-128 (Pubitemid 29088858)
-
(1999)
Surgery Today
, vol.29
, Issue.2
, pp. 121-128
-
-
Sakuma, T.1
Takahashi, K.2
Ohya, N.3
Usuda, K.4
Handa, M.5
-
32
-
-
0030187199
-
Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia
-
(in Japanese)
-
Kobayashi J, Itoh Y, Kitamura S, Kawai T. Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia. Jpn J Pathol 1996; 44: 653-658 (in Japanese).
-
(1996)
Jpn J Pathol
, vol.44
, pp. 653-658
-
-
Kobayashi, J.1
Itoh, Y.2
Kitamura, S.3
Kawai, T.4
|